文献速递前列腺癌

雷公藤活性成分雷公藤红素抑制前列腺癌骨转移

Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2017-02-14

本研究以PC-3细胞模型体外评估雷公藤红素对增殖、迁移、组织侵袭及血管内皮生长因子(VEGF)分泌的影响,并用胫骨内注射小鼠模型评估其体内对前列腺癌骨转移的作用。结果显示雷公藤红素预处理以剂量依赖方式显著降低PC-3细胞增殖、迁移、穿膜侵袭及VEGF分泌,8 μmol l-1预处理在小鼠体内几乎未发生骨侵袭,作者认为雷公藤红素可能具有预防前列腺癌骨转移的潜力。

要点

  • 雷公藤红素预处理以剂量依赖方式显著降低PC-3细胞增殖。
  • 雷公藤红素显著减少PC-3细胞穿膜侵袭并剂量依赖降低VEGF分泌。
  • 8 μmol l-1雷公藤红素预处理在 mice 模型中几乎未发生骨侵袭。

核心结论

  • 作者认为雷公藤红素可能具有预防前列腺癌骨转移的潜力。

研究设计与样本

  • 采用PC-3细胞模型进行体外增殖、迁移(划痕愈合实验)、组织侵袭(Transwell-Matrigel穿透实验)及VEGF分泌(酶联免疫吸附实验)检测。
  • 采用胫骨内注射小鼠模型评估雷公藤红素对前列腺癌骨转移的体内作用。

主要发现

  • 雷公藤红素预处理以剂量依赖方式显著降低PC-3细胞增殖,细胞迁移较对照明显减慢。
  • 雷公藤红素给药后穿透凝胶膜的细胞显著减少,骨骼侵袭能力以剂量依赖方式显著降低。
  • VEGF分泌呈显著剂量依赖性下降。
  • 体内小鼠模型中,8 μmol l-1雷公藤红素预处理抑制PC-3细胞致瘤性,与对照注射相比几乎未发生骨侵袭。
  • 苏木精-伊红染色组织学检查显示,注射雷公藤红素预处理PC-3细胞的胫骨保留自然骨结构。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment failure of prostate cancer (PCa) is often due to bone metastasis. Celastrol, an active constituent of Tripterygium wilfordii roots, has shown anti-tumor effects in previous studies in accordance with its indication in traditional Chinese medicine. METHODS: Using a PC-3 cell model, in vitro assays were performed to evaluate the effects of celastrol on proliferation, migration (wound healing assay), tissues invasion (Transwell-Matrigel penetration assay) and vascular endothelial growth factor (VEGF) secretion (enzyme-linked immunosorbent assay). An intra-tibia injection mouse model was used to assess the effect of celastrol on PCa bone metastasis in vivo. RESULTS: Pretreatment with celastrol significantly reduced proliferation of PC-3 cells in a dose-dependent manner and cell migration was much slower than in controls. Significantly fewer cells penetrated the gel-membrane after celastrol administration and their skeletal invasive ability was significantly reduced in a dose-dependent manner. Correspondingly, a significant, dose-dependent decrease in VEGF secretion was observed. In the in vivo mouse model, pretreatment with celastrol (8 μmol l-1) inhibited the tumorigenicity of PC-3 cells so that almost no bone invasion occurred as compared with control injections. Histological examinations using hematoxylin and eosin staining showed that tibiae injected with celastrol pretreated PC-3 cells retained their natural bone structure. CONCLUSIONS: Celastrol may have preventive potential against PCa bone metastasis.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Kuchta K, Xiang Y, Huang S, et al. Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis. Prostate Cancer Prostatic Dis. 2017. PMID: 28195223. doi:10.1038/pcan.2016.61

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。